Skip to main content

UBS Group AG

Position in APGE — Apogee Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in APGE

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$26,789,027
-$69,529,060 QoQ
Shares Held
201,831
-82.4% QoQ
Ownership
0.267%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#57
of 285 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in APGE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. APGE ranks #60 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in APGE

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $26,789,027 201,831
2026-03-31 $96,318,087 1,144,328
2025-12-31 $73,579,865 974,826
2025-09-30 $31,762,743 799,465
2025-06-30 $4,653,827 107,157
2025-03-31 $26,223,320 701,909
2024-12-31 $24,520,255 541,286
2024-09-30 $3,043,906 51,820
2024-06-30 $1,986,781 50,490
2024-03-31 $5,052,259 76,031
2023-09-30 $75,764 3,557